Pm. Grob et al., PROPHYLAXIS AGAINST HIV-1 INFECTION IN CHIMPANZEES BY NEVIRAPINE, A NONNUCLEOSIDE INHIBITOR OF REVERSE-TRANSCRIPTASE, Nature medicine, 3(6), 1997, pp. 665-670
Citations number
34
Categorie Soggetti
Medicine, Research & Experimental",Biology,"Cell Biology
Chimpanzees were challenged with HIV-1(IIB) while receiving a short re
gimen of nevirapine (Viramune), a nonnucleoside inhibitor of HIV-1 rev
erse transcriptase. The untreated, control chimpanzee developed an inf
ection characterized by seroconversion, viremia in peripheral blood mo
nonuclear cells (PBMCs), and plasma positive for viral RNA. In contras
t, the three nevirapine-treated chimpanzees remained negative for all
viral markers with the exception of nested polymerase chain reaction (
PCR) analysis of PBMCs for viral DNA. Although PBMCs from the three ne
virapine-treated chimpanzees tested intermittently positive for viral
DNA, this PCR signal disappeared and remained negative for the final f
ive months of the study. These data indicate that orally administered
nevirapine provided protection from HIV-1 infection in the chimpanzee
model.